Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v1-EN
Language French English
Date Updated 2024-05-30 2024-04-09
Drug Identification Number 02494639 02494639
Brand name CREON MINIMICROSPHERES 35 CREON MINIMICROSPHERES 35
Common or Proper name PROTEASE AMYLASE LIPASE PROTEASE AMYLASE LIPASE
Company Name BGP PHARMA ULC BGP PHARMA ULC
Ingredients PROTEASE AMYLASE LIPASE PROTEASE AMYLASE LIPASE
Strength(s) 2240UNIT 35700UNIT 35000UNIT 2240UNIT 35700UNIT 35000UNIT
Dosage form(s) CAPSULE (DELAYED RELEASE) CAPSULE CAPSULE (DELAYED RELEASE) CAPSULE
Route of administration ORAL ORAL
Packaging size 100BT 100BT
ATC code A09AA A09AA
ATC description DIGESTIVES, INCL ENZYMES DIGESTIVES, INCL ENZYMES
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2024-03-12 2024-03-12
Estimated end date 2024-05-23 2024-05-21
Actual end date 2024-05-22
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Globally Allocated SKUs Globally Allocated SKUs
Health Canada comments